廣告
香港股市 已收市
  • 恒指

    18,578.30
    +102.38 (+0.55%)
     
  • 國指

    6,572.45
    +25.16 (+0.38%)
     
  • 上證綜指

    3,140.72
    +35.90 (+1.16%)
     
  • 道指

    38,675.68
    +449.98 (+1.18%)
     
  • 標普 500

    5,127.79
    +63.59 (+1.26%)
     
  • 納指

    16,156.33
    +315.33 (+1.99%)
     
  • Vix指數

    13.92
    +0.43 (+3.19%)
     
  • 富時100

    8,213.49
    +41.34 (+0.51%)
     
  • 紐約期油

    78.90
    +0.79 (+1.01%)
     
  • 金價

    2,325.50
    +16.90 (+0.73%)
     
  • 美元

    7.8159
    +0.0056 (+0.07%)
     
  • 人民幣

    0.9220
    -0.0044 (-0.47%)
     
  • 日圓

    0.0506
    -0.0003 (-0.49%)
     
  • 歐元

    8.4161
    +0.0098 (+0.12%)
     
  • Bitcoin

    65,272.38
    +1,573.91 (+2.47%)
     
  • CMC Crypto 200

    1,407.01
    +94.38 (+7.19%)
     

Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating

Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating

Agios Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. Is Agios Pharmaceuticals Stock A Buy?